A groundbreaking study from U-M’s Rogel Cancer Center reveals how mutations in a single gene may drive both the development of prostate cancer and resistance to treatment. Researchers examined commonly altered genes in prostate tumors and uncovered their critical role in cancer progression. The findings could reshape how doctors approach treatment—read the full article to learn more.
We use cookies to ensure you get the best experience on our website. By using this site, you accept our use of cookies.